High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving Remicade
Status:
Completed
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
The goal of this study will be to assess the safety and efficacy of high-dose interval
Vitamin D3 therapy in children and young adults with Inflammatory Bowel Disease being treated
with serial Remicade infusions.
Phase:
Phase 3
Details
Lead Sponsor:
Boston Children's Hospital Boston Children’s Hospital
Treatments:
Cholecalciferol Ergocalciferols Infliximab Vitamin D Vitamins